| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Salidroside | Acute Lymphoblastic Leukemia | 1 | PM | 33968167 | 📋 | Salidroside overcomes dexamethasone resistance in T-acute lymphoblastic leukemia cells |
| Salidroside | Aplastic Anemia | 1 | PM | 37439434 | 📋 | Salidroside affects the Th17/Treg cell balance in aplastic anemia via the STAT3/HIF-1α/RORγt pathway |
| Salidroside | Chronic Myeloid Leukemia | 2 | PM | 36369630 | 📋 | Mechanism of salidroside in the treatment of chronic myeloid leukemia based on the network pharmacology and molecular docking |
| Salidroside | Chronic Myeloid Leukemia | 1 | PM | 34539845 | 📋 | Salidroside inhibits chronic myeloid leukemia cell proliferation and induces apoptosis by regulating the miR-140-5p/wnt5a/β-catenin axis |
| Salidroside | Platelet Aggregation | 1 | PM | 32352928 | 📋 | Salidroside inhibits platelet function and thrombus formation through AKT/GSK3β signaling pathway |
| Salidroside | Thrombosis | 1 | PM | 32352928 | 📋 | Salidroside inhibits platelet function and thrombus formation through AKT/GSK3β signaling pathway |
